Select Medical Holdings Corporation (NYSE:SEM – Get Free Report) has received a consensus rating of “Hold” from the seven analysts that are presently covering the firm, Marketbeat.com reports. Six investment analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $15.50.
SEM has been the topic of a number of recent analyst reports. Mizuho restated a “neutral” rating and set a $16.50 price objective (down from $17.00) on shares of Select Medical in a research note on Tuesday, May 12th. Zacks Research raised shares of Select Medical from a “strong sell” rating to a “hold” rating in a research note on Monday, May 4th. Finally, Weiss Ratings upgraded shares of Select Medical from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, June 4th.
Hedge Funds Weigh In On Select Medical
Select Medical Stock Performance
SEM opened at $16.51 on Friday. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.88. The business’s 50 day moving average is $16.53 and its 200-day moving average is $16.08. The stock has a market cap of $2.05 billion, a PE ratio of 15.58, a price-to-earnings-growth ratio of 0.95 and a beta of 1.01. Select Medical has a twelve month low of $11.65 and a twelve month high of $16.99.
Select Medical (NYSE:SEM – Get Free Report) last posted its earnings results on Thursday, April 30th. The health services provider reported $0.36 EPS for the quarter, missing the consensus estimate of $0.43 by ($0.07). Select Medical had a net margin of 2.42% and a return on equity of 6.62%. The business had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.41 billion. During the same quarter in the prior year, the business earned $0.44 earnings per share. The firm’s revenue was up 5.0% compared to the same quarter last year. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. On average, analysts predict that Select Medical will post 1.26 earnings per share for the current year.
Select Medical Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, May 28th. Investors of record on Thursday, May 14th were issued a dividend of $0.0625 per share. The ex-dividend date of this dividend was Thursday, May 14th. This represents a $0.25 annualized dividend and a yield of 1.5%. Select Medical’s payout ratio is presently 23.58%.
About Select Medical
Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.
Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.
Featured Stories
- Five stocks we like better than Select Medical
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.
